Quarterly report [Sections 13 or 15(d)]

Income Taxes (Tables)

Income Taxes (Tables)

9 Months Ended

Sep. 30, 2025

Schedule of Segment Reporting Information

Segment Reporting for the Three Months Ended September 30, 2025


	Treatment		Services			Segments Total		Corporate ⁽¹⁾			Consolidated Total
Revenue from external customers	$	13,114	$	4,340		$	17,454	$	—		$	17,454
Cost of Goods Sold:
Payroll and benefits expenses		4,809		2,358			7,167		—			7,167
Material and supplies expenses		2,158		—			2,158		—			2,158
Disposal expenses		1,075		—			1,075		—			1,075
Transportation expenses		361		—			361		—			361
Subcontract expenses		—		118			118		—			118
Other cost of goods sold ⁽²⁾		2,445		1,573			4,018		—			4,018
Total cost of goods sold		10,848		4,049			14,897		—			14,897
Gross profit		2,266		291			2,557		—			2,557
SG&A:
Payroll and benefits		947		547			1,494		997			2,491
Other SG&A ⁽³⁾		386		199			585		1,007			1,592
Total SG&A		1,333		746			2,079		2,004			4,083
Research and development		257		2			259		83			342
Loss on disposal of property and equipment		4		—			4		—			4
Income (loss) from operations	$	672	$	(457	)	$	215	$	(2,087	)		(1,872	)
Interest income												266
Interest expense												(116	)
Interest expense-financing fees												(22	)
Other expense												(18	)
Loss from continuing operations before taxes												(1,762	)
Income tax expense												—
Loss from continuing operations, net of taxes											$	(1,762	)

Segment Reporting for the Three Months Ended September 30, 2024


	Treatment			Services		Segments Total			Corporate ⁽¹⁾			Consolidated Total
Revenue from external customers	$	9,064		$	7,748	$	16,812		$	—		$	16,812
Cost of goods sold:
Payroll and benefit expenses		4,275			2,636		6,911			—			6,911
Material and supplies expenses		1,035			—		1,035			—			1,035
Disposal expenses		788			—		788			—			788
Transportation expenses		322			—		322			—			322
Subcontract expenses		—			2,135		2,135			—			2,135
Other cost of goods sold ⁽²⁾		2,234			2,053		4,287			—			4,287
Total cost of goods sold		8,654			6,824		15,478			—			15,478
Gross profit		410			924		1,334			—			1,334
SG&A:
Payroll and benefits		743			643		1,386			848			2,234
Other SG&A ⁽³⁾		341			172		513			885			1,398
Total SG&A		1,084			815		1,899			1,733			3,632
Research and development		205			34		239			64			303
(Loss) income from operations	$	(879	)	$	75	$	(804	)	$	(1,797	)		(2,601	)
Interest income													292
Interest expense													(121	)
Interest expense-financing fees													(18	)
Other income													59
Loss from continuing operations before taxes													(2,389	)
Income tax expense													6,417
Loss from continuing operations, net of taxes												$	(8,806	)

Segment Reporting for the Nine Months Ended September 30, 2025


	Treatment			Services			Segments Total			Corporate ⁽¹⁾			Consolidated Total
Revenue from external customers	$	33,696		$	12,263		$	45,959		$	—		$	45,959
Cost of Goods Sold:
Payroll and benefits expenses		13,988			6,245			20,233			—			20,233
Material and supplies expenses		4,744			—			4,744			—			4,744
Disposal expenses		2,391			—			2,391			—			2,391
Transportation expenses		1,222			—			1,222			—			1,222
Subcontract expenses		—			1,184			1,184			—			1,184
Other cost of goods sold ⁽²⁾		7,269			4,155			11,424			—			11,424
Total cost of goods sold		29,614			11,584			41,198			—			41,198
Gross profit		4,082			679			4,761			—			4,761
SG&A:
Payroll and benefits		2,763			1,732			4,495			2,869			7,364
Other SG&A ⁽³⁾		1,276			573			1,849			3,015			4,864
Total SG&A		4,039			2,305			6,344			5,884			12,228
Research and development		780			29			809			228			1,037
Loss (gain) on disposal of property and equipment		3			(5	)		(2	)		—			(2	)
Loss from operations	$	(740	)	$	(1,650	)	$	(2,390	)	$	(6,112	)		(8,502	)
Interest income														901
Interest expense														(351	)
Interest expense-financing fees														(63	)
Other income														171
Loss from continuing operations before taxes														(7,844	)
Income tax expense														—
Loss from continuing operations, net of taxes													$	(7,844	)

Segment Reporting for the Nine Months Ended September 30, 2024


	Treatment			Services			Segments Total			Corporate ⁽¹⁾			Consolidated Total
Revenue from external customers	$	26,116		$	18,299		$	44,415		$	—		$	44,415
Cost of goods sold:
Payroll and benefit expenses		11,970			7,065			19,035			—			19,035
Material and supplies expenses		2,876			—			2,876			—			2,876
Disposal expenses		4,211			—			4,211			—			4,211
Transportation expenses		837			—			837			—			837
Subcontract expenses		—			6,498			6,498			—			6,498
Other cost of goods sold ⁽²⁾		7,061			4,489			11,550			—			11,550
Total cost of goods sold		26,955			18,052			45,007			—			45,007
Gross (loss) profit		(839	)		247			(592	)		—			(592	)
SG&A:
Payroll and benefits		2,145			1,799			3,944			2,517			6,461
Other SG&A ⁽³⁾		1,079			474			1,553			2,617			4,170
Total SG&A		3,224			2,273			5,497			5,134			10,631
Research and development		609			87			696			176			872
Loss on disposal of property and equiment		—			1			1			—			1
Loss from operations	$	(4,672	)	$	(2,114	)	$	(6,786	)	$	(5,310	)		(12,096	)
Interest income														679
Interest expense														(346	)
Interest expense-financing fees														(47	)
Other income														61
Loss from continuing operations before taxes														(11,749	)
Income tax expense														4,300
Loss from continuing operations, net of taxes													$	(16,049	)

⁽¹⁾	Amounts reflect the activity for corporate headquarters not included in the segment reporting information.

⁽²⁾	Other cost of goods sold for each reportable segment includes:

Treatment - lab, regulatory, repair and maintenance, depreciation and amortization, travel, outside services and general expenses.

Services - material and supplies, disposal, transportation, lab, regulatory, repair and maintenance, depreciation and amortization, travel, outside services and general expenses.

⁽³⁾	Other SG&A for each reportable segment and Corporate includes:

Treatment-depreciation and amortization, travel, outside services, repair and maintenance and general expenses.

Services- travel, outside services, repair and maintenance and general expenses.

Corporate-repair and maintenance, depreciation and amortization, travel, public company, outside services and general expenses.

Schedule of Depreciation and Amortization

The following table presents depreciation and amortization for the three and nine months ended September 30, (in thousand):


	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2025		2024		2025		2024
Treatment	$	387	$	370	$	1,158	$	1,104
Services		28		44		109		133
Total segment		415		414		1,267		1,237
Corporate		11		19		32		58
Total	$	426	$	433	$	1,299	$	1,295
Depreciation and amortization	$	426	$	433	$	1,299	$	1,295

Schedule of Capital Expenditures

The following table presents capital expenditures for the three and nine months ended September 30, (in thousand):

Schedule of Capital Expenditures


	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2025			2024			2025			2024
Treatment	$	1,145		$	1,203		$	2,525		$	1,820
Services		31			180			83			404
Total segment		1,176			1,383			2,608			2,224
Corporate		—			—			—			—
Total	$	1,176	⁽¹⁾	$	1,383	⁽²⁾	$	2,608	⁽¹⁾	$	2,224	⁽²⁾
Capital expenditures	$	1,176	⁽¹⁾	$	1,383	⁽²⁾	$	2,608	⁽¹⁾	$	2,224	⁽²⁾

⁽¹⁾	Net of financed amount of $30 and $162 for the three and nine months ended September 30, 2025, respectively.

⁽²⁾	Net of financed amount of $361 and $406 for the three and nine months ended September 30, 2024, respectively.